- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 33.34M sh |
| Capex | FY 2024 · Dec 31, 2024 | 810K |
| Capex | FY 2024 · Dec 31, 2024 | $133.42K |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 8.12M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$534.07K |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $25.44K |
| Current Liabilities | FY 2024 · Dec 31, 2022 | $20.58K |
| Total Liabilities | FY 2024 · Dec 31, 2022 | $20.58K |
| Current Assets | FY 2024 · Dec 31, 2022 | $25.44K |
| Total Assets | FY 2024 · Dec 31, 2022 | $78.87K |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.08 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.08 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $553.24K |
| Operating Income | FY 2024 · Dec 31, 2022 | −$657.38K |